Sandoz Group (OTCMKTS:SDZNY) Sees Strong Trading Volume – What’s Next?

Posted by Nicole Kennedy on Feb 17th, 2026

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) shares saw strong trading volume on Tuesday . 90,759 shares were traded during mid-day trading, an increase of 240% from the previous session’s volume of 26,684 shares.The stock last traded at $86.64 and had previously closed at $85.73.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised Sandoz Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Two investment analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, Sandoz Group currently has an average rating of “Strong Buy”.

Check Out Our Latest Stock Analysis on SDZNY

Sandoz Group Stock Performance

The company has a quick ratio of 0.82, a current ratio of 1.29 and a debt-to-equity ratio of 0.62. The business has a 50-day moving average of $76.77 and a 200-day moving average of $67.81.

About Sandoz Group

(Get Free Report)

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.